Singular Genomics Announces Closing of Acquisition by Deerfield Management
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 21 2025
0mins
Source: Newsfilter
Acquisition Announcement: Singular Genomics Systems, Inc. has been acquired by Deerfield Management Company for $20.00 per share, resulting in the company becoming private and suspending its stock trading on Nasdaq.
Leadership Changes: Josh Stahl has been appointed as the new CEO of Singular Genomics, with Drew Spaventa continuing as a board member and special advisor, signaling a strategic shift for the company in advancing its sequencing technologies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
